Effect of Atorvastatin on Subclinical Atherosclerosis
NCT04101136
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
80
Enrollment
OTHER
Sponsor class
Conditions
CMV
Interventions
DRUG:
Atorvastatin - placebo controlled clinical trial
Sponsor
Dr Cipto Mangunkusumo General Hospital